Functional tetrahydrobiopterin synthesis in human platelets

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• Platelet-derived nitric oxide (NO) is vital for hemostasis.
• Tetrahydrobiopterin (BH4) regulates NO synthase activity.
• The presence of functional BH4 synthesis in platelets was previously unestablished.

Purpose of the Study:

• To investigate the existence and functionality of de novo BH4 synthesis in human platelets.
• To assess the impact of external factors like glucocorticoid therapy and storage on platelet BH4 synthesis.

Main Methods:

• Quantification of mRNA expression for key BH4 synthesis genes (GTPCH, 6-pyruvoyl tetrahydropterin synthase, sepiapterin reductase).
• Measurement of enzymatic activities related to BH4 synthesis.
• Determination of intraplatelet pteridine levels.

Main Results:

• Healthy platelets exhibit functional BH4 synthesis, confirmed by gene expression and enzyme activity.
• Biopterin is the primary intraplatelet pteridine; neopterin is absent.
• Platelet storage and prolonged glucocorticoid treatment significantly reduce GTPCH expression and activity, diminishing BH4 synthesis.

Conclusions:

• Human platelets possess a functional de novo BH4 synthesis pathway.
• Platelet BH4 synthesis is susceptible to external factors, including storage duration and glucocorticoid administration.
• These findings enhance understanding of platelet biology and pathobiology in human health and disease.